Company Chiome Bioscience Inc.

Equities

4583

JP3205350006

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
124 ^JPY	+3.33%		+1.64%	-8.15%

Apr. 01	Chiome Bioscience Cancels License Agreements with ADC Therapeutics	MT
Feb. 13	Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	CI

Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Number of employees: 53

JPY in Million	2022	Weight	2023	Weight	Delta
Drug Discovery Support 100.0 %	631	100.0 %	682	100.0 %	+8.19%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 96.6 %	597	94.7 %	659	96.6 %	+10.40%
Singapore 2.8 %	25	4.0 %	19	2.8 %	-24.17%
Europe 0.6 %	8	1.3 %	4	0.6 %	-52.09%

Managers	Title	Age	Since
Shigeru Kobayashi PSD	President	70	09-03-31
Arihiko Bijohira BRD	Director/Board Member	45	12-12-31

Members of the board	Title	Age	Since
Akiyuki Furuya BRD	Director/Board Member	79	17-02-28
Haruhisa Kubota BRD	Director/Board Member	74	19-03-27
Shigeru Kobayashi PSD	President	70	09-03-31
Arihiko Bijohira BRD	Director/Board Member	45	12-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	56,362,900	50,503,251 ( 89.60 %)	6,149 ( 0.0109 %)	89.60 %

Name	Equities	%	Valuation
Kenji Watanabe 1.783 %	1,000,000	1.783 %	787 980 ¥
Kunihiro Ohta 1.717 %	962,700	1.717 %	758 588 ¥
Growth Capital KK 1.676 %	940,000	1.676 %	740 701 ¥
Koji Yoshimura 1.070 %	600,000	1.070 %	472 788 ¥
Tetsuo Iisaku 0.8862 %	497,000	0.8862 %	391 626 ¥
Shigekazu Hirata 0.8113 %	455,000	0.8113 %	358 531 ¥
Fukutaro Yamato 0.7132 %	400,000	0.7132 %	315 192 ¥
Shigeru Kobayashi 0.4390 %	246,200	0.4390 %	194 001 ¥
Chiome Bioscience Restricted Stock Compensation Plan 0.3001 %	168,300	0.3001 %	132 617 ¥
Goldman Sachs Asset Management International 0.0499 %	28,000	0.0499 %	22 063 ¥

Name	Equities	%	Valuation
CHIOME BIOSCIENCE INC. 0.01%	6,100	0.01%	4,807 $

Chiome Bioscience, Inc.

Sumitomo Fudosan Nishi-Shinjuku Bldg 3-12-1 Hon-machi

151-0071, Tokyo

http://www.chiome.co.jp

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
CHIOME BIOSCIENCE INC.	-8.15%	44.58M
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research